Antipsychotics explained
Antipsychotics explained — what they actually do and what to watch during long-term use
Antipsychotics act on dopamine receptors, and during acute psychosis or mania they can be lifesaving for functioning and safety. With long-term use, though, they require active monitoring of metabolism, movement, and hormones. We explain the mechanism and what to watch.
Antipsychotics are among the most effective medications for acute psychosis, mania, and severe agitation — within days they can restore sleep, reduce hallucinations, ease delusions, and bring back enough judgment for further treatment to continue. At the same time, they're among the medications with the widest range of long-term risks — metabolic, hormonal, and movement-related. This article explains how they work, what to monitor during long-term use — and where biochemical context per the orthomolecular approach can add to the picture.
Does this sound familiar?
If this sounds like you, keep reading.
- you take an antipsychotic and want to know why it causes weight gain or fatigue
- you feel an inner restlessness you can't sit still through (possible akathisia)
- you're curious which blood tests should be done regularly during long-term use
- you're looking for information on what can support the body alongside the medication without replacing treatment.
How antipsychotics work
Most antipsychotics block or modulate dopamine D2 receptors; newer ("second-generation") ones also affect serotonin, histamine, and adrenergic pathways. Besides regulating psychosis, dopamine also plays a role in motivation, movement, the experience of pleasure, and hormonal regulation — which is why excessive blockade brings, alongside the therapeutic effect, stiffness, emotional blunting, and sexual dysfunction.
The difference between first- and second-generation antipsychotics: older medications (e.g. haloperidol) have stronger dopamine blockade and more movement-related side effects; newer ones have a lower movement-related risk, but the burden shifts toward metabolic, hormonal, and cardiovascular effects. The label "atypical" doesn't mean risk-free.
The benefit during an acute crisis
During psychosis or mania, the medication reduces hallucinations, eases delusions, restores sleep, reduces agitation, organizes thinking, and restores enough judgment for safety and continued cooperation with treatment. This is a real, well-documented benefit in the acute phase.
What to monitor with long-term use
- Metabolic changes — appetite, insulin sensitivity, and energy expenditure can worsen even before a visible weight increase; that's why blood glucose, glycated hemoglobin, lipid profile, waist circumference, and blood pressure are monitored, not just weight.
- Movement-related symptoms — acute dystonia (painful muscle contraction), drug-induced parkinsonism (stiffness, tremor), akathisia (intense inner restlessness, a need to keep moving — often mistaken for anxiety or worsening mania), and tardive dyskinesia (involuntary movements after longer-term use).
- Prolactin — strong dopamine blockade raises prolactin, which can cause cycle irregularities, breast changes, sexual dysfunction, and reduced bone density.
- Sedation — useful in an acute crisis, but during long-term use it can interfere with rehabilitation, work, exercise, and everyday functioning.
A rare but urgent complication is neuroleptic malignant syndrome — high fever, severe muscle stiffness, confusion, and unstable vital signs; it requires immediate medical attention.
When to add biochemical context per the orthomolecular approach
Biochemical testing never delays needed acute treatment, and a Walsh biotype is not a diagnosis of schizophrenia or psychosis — it is supplementary context, only after psychiatric stabilization. After stabilization it can make sense to look at copper-zinc balance, methylation status (histamine, SAM, SAH, homocysteine), oxidative stress, vitamin D, or gut health — factors that can influence overall resilience.
Nutritional support (adequate protein, controlling simple sugars, strength and aerobic activity, supplementing zinc and vitamin D where a deficiency is confirmed) cannot replace needed medication, but it can ease the physical wear that long-term use brings.
Why movement is monitored, not just mood
Akathisia (inner restlessness, an inability to sit still) is easily mistaken in practice for worsening anxiety or mania — and when misread, the response is often, paradoxically, an increase in the dose of the medication causing it, which makes things worse. Precisely naming the symptom to the treating doctor ("I feel an inner restlessness, I need to move" rather than just "I'm anxious") can therefore change the next treatment step.
Similarly, early recognition of subtle involuntary movements (small movements of the tongue, lips, fingers) allows a medication change to be considered in time, before fully developed tardive dyskinesia sets in, which can be partly permanent even after stopping the medication.
A sequence to follow before any dose change
Recommended sequence: (1) manage acute symptoms, (2) restore sleep, nutrition, hydration, and safety, (3) assess what is symptom improvement and what is a side effect, (4) review metabolic, hormonal, neurological, and cardiovascular risks, (5) run targeted biochemical tests, (6) gradually correct deficiencies, (7) find the lowest effective dose, (8) consider gradual tapering only after lasting stability and solely under a psychiatrist's supervision.
Abrupt discontinuation can trigger insomnia, anxiety, nausea, sweating, agitation, involuntary movements, or a relapse of psychosis — so the dose is never reduced on your own.
A practical first step
PsyLab is not a psychiatric practice and does not make decisions about treating psychosis, mania, or schizophrenia — the dose and any change is decided solely by your treating psychiatrist.
1. If you are psychiatrically stable and interested in supplementary biochemical context, fill out the free screening.
2. Discuss the findings at a 45-minute consultation (€75) — together we'll assess what's worth discussing with your psychiatrist.
Sources
Next step
If you recognize yourself in this article, the most practical next step is the free 5-minute screening questionnaire — it shows your likely biotype and a recommended first test.